Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial
Takeda
Vianney Tricou; Xavier Sáez-Llorens; Delia Yu; Luis Rivera; José Jimeno; Ana Cecilia Villarreal; Epiphany Dato; Onix Saldaña de Suman; Nathali Montenegro; Rodrigo DeAntonio; Sonia Mazara; Maria Vargas; Debbie Mendoza; Martina Rauscher; Manja Brose; Inge Lefevre; Suely Tuboi; Astrid Borkowski; Derek Wallace